Qatar Universal Diabetes Outcomes (QUDOS) Study
- Conditions
- Diabetes MellitusType 2 Diabetes Mellitus
- Registration Number
- NCT02660476
- Lead Sponsor
- Weill Cornell Medical College in Qatar
- Brief Summary
QUDOS is a cross-sectional population study aiming to answer key questions about diabetes and its complications in Qatar as well as identify factors associated with the development and progression of diabetes complications.
- Detailed Description
QUDOS aims to gain a better understanding of diabetes in primary and secondary care over a period of 24 months.
A range of patients with diabetes will be sampled (including those with Type 1 diabetes as this group is under-studied in Qatar). This will be important in designing appropriate intervention plans that will improve diabetic patients' health conditions to prevent or delay the onset of complications and will provide a strong foundation for longitudinal study.
The broad objectives of the study are:
QUDOS 1: Aims to recruit 1,700 diabetic patients (including 200 with type 1 diabetes mellitus (independent of healthcare setting)) attending the hospitals and primary care and to collect the following data:
* Demographics: age, sex, ethnicity, socio-economic background, smoking status;
* Anthropometrics: vital signs, height, weight, body fat percentage, fat mass, neck and waist circumference;
* Medical History: medications, complications, comorbidities, latest HbA1c and lipid profiles and family medical history;
* Routine laboratory data;
* Lifestyle: diet, physical activity,;
* Sleep: quality and daytime sleepiness;
* Cognition and Mental Health: depression, anxiety, stress and memory;
* Diabetes microvascular complications: diabetic neuropathy, urine albumin/creatinine ratio; routine retinal screening data.
* Gut microbiome from a stool sample
QUDOS 2: To further characterise 500 patients, from the total 1500 patients with T2DM recruited in QUDOS 1, who accept to continue with QUDOS 2 (a more detailed study and assessment).
This phase aims to concentrate on the following aspects:
* Obstructive sleep apnoea;
* Sleep duration and quality;
* Diet;
* Objective physical activity;
* Stress;
* Quality of Life;
* Depression and anxiety;
* Perceived control of health;
* Detailed neuropathy screening;
* Cardiovascular function;
* Cognitive function;
* Biological samples.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 475
- Type 1 and Type 2 diabetes mellitus;
- Male or Female;
- Resident in Qatar;
- MENA birthplace and family origin;
- 18-70 years old;
- Capable to give informed consent and complete the study.
- Known pregnancy or planning pregnancy during the duration of study; 2. Congenital disorders; 3. Terminal illness; 4. Enrolled in a clinical trial involving medication; 5. Uncontrolled mental illness preventing participation; 6. Those who have already experienced a definitive microvascular complication:
i. End-stage renal disease; ii. Major amputation; iii. Blindness.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diabetes Complications (Nephropathy, Neuropathy, Retinopathy) Baseline (Cross-Sectional) Our primary analyses will be conducted to explore the potential cross-sectional relationships amongst proposed factors related to type 2 diabetes complications
- Secondary Outcome Measures
Name Time Method Sleep and sleep related breathing disorders Baseline (Cross-Sectional) To assess the relationships between T2DM and sleep disordered breathing, sleep duration and sleep quality through a home sleep study
Mental Health Baseline (Cross-Sectional) To assess the relationships between T2DM and depression through questionnaires
Physical activity Baseline (Cross-Sectional) To assess the relationships between T2DM and physical activity using an Actiwatch
Trial Locations
- Locations (1)
Weill Cornell Medicine Qatar
πΆπ¦Doha, Qatar